SCHEMBL11279729

SCHEMBL11279729

NCCCCNc1ccc(O)c2c1C(=O)c1c(O)ccc(O)c1C2=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.71
MEN1 O00255 4/20 0.63
KMT2A Q03164 4/20 0.63
BLM P54132 3/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
USP2 O75604 3/20 0.63
TP53 P04637 3/20 0.63
MAPK1 P28482 3/20 0.63
RECQL P46063 3/20 0.63
TDP1 Q9NUW8 3/20 0.63
CSNK2A2 P19784 3/20 0.63
CSNK2B P67870 3/20 0.63
CSNK2A1 P68400 3/20 0.63
CSNK2A3 Q8NEV1 3/20 0.63
NSD2 O96028 3/20 0.63
LMNA P02545 2/20 0.63
NPC1 O15118 2/20 0.63
MTOR P42345 2/20 0.63
RAB9A P51151 2/20 0.63
HIF1A Q16665 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1323094 0.98 CYP19A1 (0.69) CYP19A1MEN1KMT2ABLMSMN1; SMN2
SCHEMBL10524500 0.95 CYP19A1 (0.73) CYP19A1MEN1KMT2ABLMSMN1; SMN2
Hydrochloric Acid SCHEMBL11150067 0.94 CYP19A1 (0.71) CYP19A1MEN1KMT2ABLMSMN1; SMN2
SCHEMBL14228462 0.92 CYP19A1 (0.61) CYP19A1MEN1KMT2ABLMSMN1; SMN2
SCHEMBL1323801 0.90 CYP19A1 (0.59) CYP19A1MEN1KMT2ABLMSMN1; SMN2
SCHEMBL10523397 0.89 MEN1 (0.75) CYP19A1MEN1KMT2ABLMSMN1; SMN2
SCHEMBL4885984 0.88 CYP19A1 (0.68) CYP19A1MEN1KMT2ABLMSMN1; SMN2
SCHEMBL11517791 0.88 CYP19A1 (0.68) CYP19A1MEN1KMT2ABLMSMN1; SMN2
SCHEMBL29350310 0.88 CYP19A1 (0.68) CYP19A1MEN1KMT2ABLMSMN1; SMN2
SCHEMBL10620370 0.87 CYP19A1 (0.62) CYP19A1MEN1KMT2ABLMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0021622-B1 1-(AMINOALKYLAMINO)-5,8-DIHYDROXY-4-SUBSTITUTED-ANTHRAQUINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AMERICAN CYANAMID COMPANY (US) 1982-10-20 EP claimed
US-4275009-A ANTITUMOR, CHELATION AMERICAN CYANAMID COMPANY (US) 1981-06-23 US claimed
EP-0021622-A1 1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1981-01-07 EP claimed
US-4275009-A ANTITUMOR, CHELATION AMERICAN CYANAMID COMPANY (US) 1981-06-23 US disclosed
EP-0021622-A1 1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1981-01-07 EP disclosed